|
Market Cap (17-May) $65,067,412 (361st) |
Close (30-Jun) $0.100 |
Volume (30-Jun) 1,754,344 |
Shortsold (29-Nov) 5,010,077 (0.32%) (345th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -1.3 |
IHL released this announcement to the ASX on 29 November 2022, 8:22. The announcement is marked as price sensitive, and is 3 page(s) in length and 149.66kb in size.
You can view all announcements from IHL and see how they appear on a price chart on the announcements page.
At the date of this announcement, IHL was 2.263% short sold according to ASIC data. It was ranked the 118th most shorted stock on the ASX. It remains ranked 345th as of the latest reported data (29 November 2023).
| Other Recent Announcements from IHL | |
|---|---|
| Change of Director's Interest Notice | 30 June 2023, 13:57 |
| Change of Registered Office | 26 June 2023, 15:51 |
| IHL Announcement - H.C. Wainwright Virtual Conference | 23 June 2023, 8:17 |
| IHL commences manufacturing of skin therapeutics | 29 November 2022, 8:22 |
| IHL Commences Manufacturing for Novel Addiction Treatments | 25 November 2022, 8:20 |
| Addendum to Notice of Annual General Meeting | 21 November 2022, 8:19 |
| Incannex Development Update for IHL-42X | 17 November 2022, 8:19 |
You must be logged in to post a reply.
Incannex Healthcare 